Arch Point Investors Sanofi Transaction History

Arch Point Investors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $1.02 Million - $1.12 Million	-20,585 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$45.46 - $50.51 $106,376 - $118,193	2,340 Added 12.83%	20,585 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $132,955 - $151,504	2,935 Added 19.17%	18,245 $887,000
Q3 2020 Nov 13, 2020	BUY	$49.47 - $53.77 $94,487 - $102,700	1,910 Added 14.25%	15,310 $768,000
Q2 2020 Jul 31, 2020	SELL	$42.91 - $52.5 $145,035 - $177,450	-3,380 Reduced 20.14%	13,400 $684,000
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $26,804 - $36,420	705 Added 4.39%	16,780 $734,000
Q1 2019 May 10, 2019	SELL	$40.83 - $45.43 $3,878 - $4,315	-95 Reduced 0.59%	16,075 $712,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $49,671 - $54,410	1,320 Added 8.89%	16,170 $647,000
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $62,147 - $73,384	1,450 Added 10.82%	14,850 $639,000
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $630,336 - $674,556	13,400	13,400 $667,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.